Mutual Of America Capital Management LLC Novavax Inc Transaction History

Mutual Of America Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$36.28 - $75.29 $343,462 - $712,770	-9,467 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$69.73 - $142.9 $24,684 - $50,586	-354 Reduced 3.6%	9,467 $697,000
Q4 2021 Feb 03, 2022	SELL	$134.56 - $217.97 $10,764 - $17,437	-80 Reduced 0.81%	9,821 $1.41 Million
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $211,048 - $321,178	1,187 Added 13.62%	9,901 $2.05 Million
Q2 2021 Aug 06, 2021	SELL	$121.0 - $257.67 $2.29 Million - $4.88 Million	-18,935 Reduced 68.48%	8,714 $1.85 Million
Q1 2021 May 13, 2021	BUY	$112.98 - $319.93 $762,840 - $2.16 Million	6,752 Added 32.31%	27,649 $5.01 Million
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $1.66 Million - $3.73 Million	20,897 New	20,897 $2.26 Million

291

93.3M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $573M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.